News

Cancer Research4d
Abstract CT185: Trispecific EGFR x cMET x VEGF antibody, TAVO412, has clinical responses in esophageal and lung cancers
Search for other works by this author on: ...
Cancer Research4d
Abstract SY27-02: Exploring the significance of somatic mtDNA mutations in the context of acute leukemia
St. Jude Children's Research Hospital, Memphis, TN.
Cancer Research6d
Former NCI Director to Lead Ohio Cancer Center
W. Kimryn Rathmell, MD, PhD, has accepted the role as CEO of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. She was ...
Cancer Research8d
Abstract 4336: Translational PK/PD modeling of MEK inhibitors: Trametinib, cobimetinib and binimetinib
Seda Pharmaceutical Development Services, Stockport, United Kingdom.
Cancer Research8d
Abstract 410: The BTK degrader BGB-16673 shows anti-tumor activity in marginal zone lymphoma models
IOR - Institute of Oncology Research, Bellinzona, Switzerland.
Cancer Research8d
Abstract 4611: Microbiome-derived indole metabolites and response to immune checkpoint inhibitors in patients with hepatocellular carcinoma
Search for other works by this author on: ...
Cancer Research8d
Abstract 1591: Mechanisms of BPM31510-induced cell death in cancer: lipid peroxidation and apoptosis pathways
Search for other works by this author on: ...
Cancer Research8d
Abstract 6331: Prevention of lung cancer growth by an edible mushroom-derived p-terphenyl antioxidant, Vialinin-A
Noorda College of Osteopathic Medicine, LLC, Provo, UT.
Cancer Research8d
Abstract 3503: ZW171, a differentiated 2+1 T cell-engaging bispecific antibody with antitumor activity in a range of mesothelin-expressing cancers
Zymeworks Inc., Vancouver, British Columbia, Canada.
Cancer Research8d
Abstract 635: Unraveling the potential of neogenin 1 in non-small cell lung cancer: A path toward innovative combination therapies
John A. Burns School of Medicine University of Hawaii at Manoa, Honolulu, HI.
Cancer Research8d
Abstract 1530: Elucidating the role of exogenous lipids in ferroptosis in castration resistant prostate cancer
Search for other works by this author on: ...
Cancer Research11d
Dietary Fat Promotes Triple-Negative Breast Cancer through FABP5–mTOR
Major Finding: Dietary ω-6 linoleic acid (LA) promotes oncogenic mTOR signaling in triple-negative breast cancer (TNBC). Concept: TNBCs express the fatty acid binding protein FABP5, which senses ω-6 ...